Xerostomia (Dry Mouth Disease) Therapeutics Market to Reach US$ 893 Million by 2028

IMARC Group, a leading market research company, has recently releases report titled "Xerostomia (Dry Mouth Disease) Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028." The study provides a detailed analysis of the industry, including the global xerostomia therapeutics market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How Big is the Xerostomia (Dry Mouth Disease) Therapeutics Market?

The global xerostomia (dry mouth disease) therapeutics market size reached US$ 714 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 893 Million by 2028, exhibiting a growth rate (CAGR) of 3.6% during 2023-2028.

Get Your Free Sample Copy of This Report: https://www.imarcgroup.com/xerostomia-therapeutics-market/requestsample

Xerostomia dry mouth disease therapeutics refer to the range of treatments and medications available to manage and alleviate the symptoms of dry mouth. They include oral rinses, prescription medications, and saliva-stimulating products. They help relieve discomfort and difficulty in speaking and swallowing, and promote oral health. They help moisturize and lubricate the oral cavity, providing temporary or long-term relief from increased dental problems. They are extensively used across hospitals, dental clinics, and other healthcare settings to deal with decreased salivary gland function. Besides this, as they enhance taste perception, the demand for xerostomia dry mouth disease therapeutics is increasing across the globe.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/xerostomia-therapeutics-market

What are the growth prospects and trends in the xerostomia (dry mouth disease) therapeutics industry?

The aging population, which is highly susceptible to dental problems, such as tooth decay, cavity, and dry mouth, represents one of the key factors catalyzing the demand for xerostomia dry mouth disease therapeutics.

Additionally, the rising awareness among individuals about oral health and the impact of dry mouth on dental hygiene and overall well-being are favoring market growth. Furthermore, the increasing prevalence of diabetes and Sjogren's syndrome, which are often associated with dry mouth, is contributing to market growth.

Moreover, advancements in the development of innovative and targeted therapeutics and increasing investments by pharmaceutical companies in research and development (R&D) activities to develop new formulations, including saliva substitutes, oral sprays, and prescription medications, that offer improved efficacy and convenience for patients are propelling the market growth.

Inquiry Before Buying: https://www.imarcgroup.com/request?type=report&id=6439&flag=F

The report has segmented the market on the basis of type, drug type and distribution channel.

Breakup by Type:
• Artificial Saliva/Saliva Substitutes
• Salivary Stimulants

Breakup by Drug Type:
• OTC
• Prescription

Breakup by Distribution Channel:
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

3M Company, Biotene (GSK plc), Parnell Pharmaceuticals Inc., Quest Products LLC, Saliwell Ltd, Sun Pharmaceutical Industries Limited and West-Ward Pharmaceutical (Hikma Pharmaceuticals plc).

IMARC Services Private Limited.
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.